Press Release
Theriva Biologics Receives Fast Track Designation From FDA For VCN-01 For Treating Metastatic Pancreatic Cancer
–News Direct–
By Kyle Anthony, Benzinga
Theriva Biologics (AMEX: TOVX) is an immuno-oncology company developing oncolytic viruses, otherwise known as cancer cell-infecting viruses, to overcome the protective barrier surrounding solid tumors and selectively kill tumor cells. As a company engaged in developing differentiated clinical-stage therapeutics, Therivas mission is to change patient outcomes by working to improve the current standard of care and transform the cancer therapy landscape.
The firms management and scientific advisory board is comprised of determined and experienced leaders who are committed to offering patients with difficult-to-treat cancers the chance of a longer life. The company recently achieved a significant milestone as the U.S. FDA granted Fast Track Designation (FTD) to its candidate VCN-01 to improve progression-free survival and overall survival in patients with metastatic pancreatic adenocarcinoma. Previously, the FDA granted orphan drug designation to VCN-01 for treatment of pancreatic ductal adenocarcinoma (PDAC).
Company Background
Founded in 2001 and operating as Synthetic Biologics from 2012, the company was previously focused on developing biologic and drug candidates for various indications, including infectious diseases and gastrointestinal disorders. The company rebranded to Theriva Biologics in September 2022 to reflect its evolving focus on oncolytic viruses and cancer therapies. Regarding the impetus behind the firms rebranding, Steven A. Shallcross, Chief Executive Officer of Theriva Biologics, said, The rebranding solidifies our strategic transformation and reflects our sharpened focus on advancing unique, oncolytic viruses optimized for IV administration. We continue to build on the incredible progress made to date and are diligently advancing our oncolytic adenovirus pipeline. This includes lead clinical-stage program VCN-01, designed to break down the tumor stroma, and preclinical-stage program VCN-11, leveraging our proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system. These two differentiated programs are intended to improve the anti-tumor effect of the oncolytic virus, co-administered chemotherapies and/or immuno-oncology therapeutics. Together, VCN-01 and VCN-11 position Theriva at the forefront of oncolytic virus development. We are excited about Therivas path towards strategic growth, renewed corporate strategy and remain on track to deliver on upcoming value-driving milestones.
Theriva Biologics Pipeline
As Steven A. Shallcrosss preceding quote suggests, Theriva Biologics' leading clinical-stage program, VCN-01, has displayed promise as a treatment solution. Presently, VCN-01 is part of an ongoing phase 2 clinical trial, entitled VIRAGE, where it is being tested in combination with standard-of-care chemotherapy for patients with pancreatic ductal adenocarcinoma (PDAC), the most common form of pancreatic cancer. VCN-01 was also administered with the checkpoint inhibitor durvalumab (an FDA-approved immunotherapy for cancer) in a phase 1 study in patients with head and neck cancers and is currently being evaluated in combination with huCART-meso cells cells manufactured using a patients own white blood cells, which are modified to target cancer cells or cells that help cancer to grow in an investigator-sponsored study in patients with either pancreatic cancer or ovarian cancer.
Beyond VCN-01, Theriva Biologics is also developing SYN-004 (ribaxamase), which is aligned with the companys oncology focus and seeks to mitigate adverse outcomes for patients who will undergo bone marrow transplant (allogeneic hematopoietic cell transplantation) to treat hematologic cancers. 80% to 90% of these patients will be treated with an intravenous -lactam antibiotic, and this antibiotic treatment has been strongly associated with increased incidence and severity of acute graft-vs-host disease (aGVHD), vancomycin-resistant Enterococci (VRE) infection and Clostridioides difficile infection (CDI). Preventing one or all of these outcomes by SYN-004 co-administration may significantly improve treatment outcomes and reduce patient mortality.
VCN-01 Receives Fast Track Designation By The U.S. FDA
Theriva Biologics achieved a significant milestone as the FDA granted Fast Track Designation (FTD) to VCN-01. This designation, in combination with gemcitabine and nab-paclitaxel standard-of-care chemotherapy drugs is aimed at improving progression-free survival and overall survival in patients with metastatic pancreatic cancer. This recognition underscores Theriva Biologics' commitment to advancing cancer treatment and the potential of VCN-01 in this field.
Pancreatic cancer is one of the leading causes of cancer death globally. The increasing incidence of this cancer across the U.S. and other parts of the world is one of the factors driving the need for drugs used in its treatment. According to research published by Fortune Business Insights, the global pancreatic cancer treatment market size was $2.86 billion in 2023 and is projected to grow from $3.30 billion in 2024 to $10.69 billion by 2032.
Attaining FTD is a seminal achievement for pharmaceutical drug companies, as the designation is designed to help treatments reach patients faster by facilitating the development and expediting the review of therapies with the potential to treat serious conditions and fill an unmet medical need. Benefits of FTD to programs include early and frequent interactions with the FDA during the clinical development process, and if relevant criteria are met, the FDA may also review portions of a marketing application before the sponsor submits the complete application.
Regarding Theriva Biologics receiving the FTD, Shallcross said, The FDAs decision to grant FTD to VCN-01 highlights the urgent need for new treatment options for PDAC, which accounts for the 4th highest cause of cancer-associated deaths in the US and Europe. VIRAGE, our Phase 2b trial evaluating VCN-01 in metastatic PDAC continues to progress, with enrollment expected to be completed in the third quarter of 2024. FTD is an important step that furthers our ability to expedite the review of and build upon the compelling clinical data that underscores VCN-01s multiple modes of action and therapeutic potential in combination with chemotherapy or immunotherapy. We will continue to deliver on our mission to advance new therapeutic options for these patients.
Based on the strength of the science and its relevance, VIRAGE was accepted for presentation as a trial-in-progress poster at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, held in Chicago, IL, from May 31-June 4.
The Path Forward
Theriva Biologics' approach to cancer treatment differentiates it from its peers, potentially placing the company in a unique market position. As incidences of pancreatic cancer continue to rise globally, drug treatment options, such as VCN-01, will likely rise in demand. With VCN-01 receiving FTD from the U.S. FDA, this milestone speaks to the drug's efficacy and long-run potential. As such, the benefit that Theriva Biologics provides and the value proposition the firm espouses could continue to grow and have increased industry resonance.
Featured photo by National Cancer Institute on Unsplash.
Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders.
This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice.
Contact Details
Benzinga
+1 877-440-9464
Company Website
View source version on newsdirect.com: https://newsdirect.com/news/theriva-biologics-receives-fast-track-designation-from-fda-for-vcn-01-for-treating-metastatic-pancreatic-cancer-427600911
Benzinga
COMTEX_453481266/2655/2024-06-07T08:44:04
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
United States, 29th Apr 2025, – San Francisco, CA — In a world that’s increasingly disconnected from nature, GroundingTime is proud to unveil its latest innovation: the Bamboo Grounding Fitted Sheet | 5X Grounding Power for Better Sleep Groundingtime — a wellness-forward, eco-conscious sleep essential designed to bring the science of grounding into your bedroom, without compromising on style, softness, or sustainability.
Nature-Inspired, Science-Backed
Grounding, also known as earthing, is the practice of connecting your body directly to the Earth’s natural electric charge. Studies suggest that this connection may support better sleep, reduce inflammation, and promote a greater sense of calm and balance.
Our Bamboo Grounding Fitted Sheet is designed to help facilitate this connection — effortlessly. Using a proprietary blend of conductive silver fibers woven into ultra-soft bamboo fabric, the sheet connects via a grounding cord to a grounded outlet, helping your body naturally sync with the Earth’s energy while you sleep.
“We wanted to take The Science Behind Grounding Therapy | How Earth’s Energy Heals – Groundingtime and make it easy, beautiful, and accessible for everyone,” says the GroundingTime product design team. “This sheet is as much about comfort as it is about connection.”
Why Bamboo?
Unlike traditional cotton or synthetic fabrics, bamboo is naturally breathable, hypoallergenic, and antimicrobial. It also happens to be one of the most sustainable resources on the planet.
Each GroundingTime sheet is made from certified organic bamboo sourced from responsibly managed forests, ensuring minimal environmental impact while delivering maximum comfort.
Key Benefits of Bamboo:
Thermoregulating & breathable
Incredibly soft — even after multiple washes
Naturally moisture-wicking and odor-resistant
Hypoallergenic — ideal for sensitive skin
Built-In Multi-Point
Grounding Therapy | 5X Enhanced Grounding Technology – Groundingtime
What sets this sheet apart is its integrated grounding grid of pure silver threads. These threads are seamlessly woven into the fabric, allowing for safe and effective conductivity without sacrificing comfort.
The sheet comes with a grounding cord and adapter that easily connects to a standard grounded outlet, giving you the benefits of grounding while you sleep — with no need to change your habits or routines.
Functional Design That Fits Your Life
The Bamboo Grounding Fitted Sheet is available in multiple sizes, with 15‘’ deep-pocket corners that fit even oversized mattresses. It’s machine-washable, easy to set up, and designed to integrate smoothly with any bedroom aesthetic.
Whether you’re new to grounding or a long-time believer in the benefits, this sheet is a simple yet powerful addition to your wellness routine.
What Customers Are Saying
“I’ve been using the GroundingTime bamboo sheet for just two weeks, and I’ve noticed deeper, more restful sleep. The fabric is unbelievably soft — I honestly don’t want to get out of bed.”
— Laura M., verified buyer
“I’ve struggled with chronic pain in my lower back for years. After sleeping on the GroundingTime bamboo sheet for just a few nights, I woke up with noticeably less stiffness and tension. It’s the first thing I’ve tried that’s made a real difference — naturally.”
— Daniel R., verified buyer
Sustainability at the Core
GroundingTime believes that wellness shouldn’t come at the expense of the planet. That’s why every sheet is packaged in plastic-free, recyclable materials, and a portion of each purchase goes toward reforestation and clean water initiatives.
Availability
The Bamboo Grounding Fitted Sheet is now available exclusively at www.groundingtime.com, with free U.S. shipping.
About GroundingTime
GroundingTime combines scientific research with natural therapy to offer a gentle, nature-based wellness solution for those living with chronic conditions, pain, and sleep challenges. Through grounding technology, we help users reduce stress, improve rest, and support overall health and mind-body balance in everyday life.
Media Contact
Organization: GroundingTime
Contact
Person: Mona
Website:
https://groundingtime.com/
Email:
hello@groundingtime.com
Country:United States
The post GroundingTime Debuts Eco-Friendly Bamboo Grounding Sheet to Redefine Rest appeared first on
Brand News 24.
It is provided by a third-party content
provider. Brand News 24 makes no
warranties or representations in connection with it.
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
United States, 29th Apr 2025, – CozyBliss, an innovator in modern home lifestyle products, is excited to announce the launch of its 2025 COOLI PRO Cooling Bedding Collection, a next-generation comfort solution designed to deliver instant cooling and long-lasting comfort throughout the night. The new collection integrates a proprietary woven pattern and Sorona® bio-based fiber technology, offering a superior sleep experience rooted in both innovation and sustainability.
Sleep Cool and Comfortable with Sorona® Fiber
At the heart of the COOLI PRO comforters is advanced Sorona® fiber technology, engineered to enhance breathability and cooling performance. Derived from 37% renewable plant-based materials, Sorona® delivers a 22% increase in loft compared to traditional polyester and improves heat dissipation by 35%. This sustainable fiber also reduces carbon emissions by up to 30% during production. Additionally, the fitted sheet fabrics include 25% GRS-certified recycled PET, further supporting CozyBliss’s commitment to environmental responsibility.
The surface of each comforter boasts a Q-Max value greater than 0.4, enabling an instant cooling effect that can reduce body temperature by 2–5°C. Crafted with precision quilting in both feathered and diamond patterns, the bedding combines tactile cooling with elevated aesthetic appeal. The 3D woven textures not only improve airflow but also provide a sleek, contemporary look that complements modern interior styles.
Stylish, Skin-Friendly, and Safe
The COOLI PRO series is available in sophisticated dual-tone colorways, including Creamy White – Misty White and Meteor Grey – Cool Grey, making it a perfect match for minimalist and modern American home décor.
Every product in the COOLI PRO collection has been independently tested and certified to meet OEKO-TEX® Standard 100, the highest safety standard. This ensures they are free from 138 potentially harmful substances, making them safe for use by all, including infants and those with sensitive skin.
Purchase Information
COOLI Series
Lightweight summer blankets with 100% poly down-alternative filling create a 3D hollow structure for enhanced elasticity and durability. Designed for summer use with excellent abrasion resistance.
COOLI PRO Series
The upgraded COOLI PRO comforter features Sorona® filling with a helical fiber structure for enhanced breathability and support. The reversible design provides both versatility and modern style.
Website: https://www.cozybliss.com/products/lightweight-natural-cooling-comforter?variant=47795869122806
The full collection is available for purchase through the CozyBliss website and Amazon CozyBliss Store.
About CozyBliss
Founded with a vision to redefine modern comfort, CozyBliss is a leading brand in American home living. The company offers an all-season, all-scene product line designed to help consumers effortlessly switch into comfort mode anytime, anywhere. By combining thoughtful design, sustainable materials, and superior craftsmanship, CozyBliss brings lasting coziness to homes around the world.
Media Contact
Organization: CozyBliss
Contact
Person: Media Relations
Website:
https://www.cozybliss.com/
Email:
marketing@cozybliss.com
Country:United States
The post CozyBliss Introduces 2025 COOLI PRO Cooling Comforter Featuring Sorona Technology appeared first on
Brand News 24.
It is provided by a third-party content
provider. Brand News 24 makes no
warranties or representations in connection with it.
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Press Release
Blue Sky Scrubs Celebrates World Environment Day with Commitment to Sustainability and Innovation
United States, 29th Apr 2025, – Austin, TX — As the world comes together to celebrate World Environment Day on June 5, Blue Sky Scrubs is proud to spotlight its ongoing commitment to protecting the planet through thoughtful, sustainable practices. The luxury medical apparel company, known for blending style with functionality, believes that caring for the environment is a natural extension of its mission to care for healthcare professionals.
In honor of World Environment Day on June 5, Blue Sky Scrubs is proud to reaffirm its commitment to protecting the planet through sustainable business practices. As a leader in luxury medical apparel, the company believes that caring for healthcare professionals also means caring for the environment they live and work in.
Blue Sky Scrubs focuses on creating long-lasting products by using premium fabrics and expert craftsmanship, helping reduce the fast-fashion waste cycle. By designing scrubs and accessories that withstand daily wear and maintain their quality over time, the company encourages a more sustainable approach to medical workwear.
In addition, Blue Sky Scrubs minimizes the use of plastic in packaging, supports local and ethical manufacturing, and donates surplus inventory to medical missions and nonprofits, ensuring that unused items serve communities in need rather than ending up in landfills.
“We are inspired every day by healthcare workers who protect and heal,” said Shelby Marquardt, founder of Blue Sky Scrubs. “Our mission is to create products that not only serve them but also help preserve the environment for future generations.”
This World Environment Day, Blue Sky Scrubs invites the healthcare community and its supporters to reflect on the small changes that, together, can make a big difference for the planet.
For more about Blue Sky Scrubs’ sustainability efforts, visit blueskyscrubs.com.
Media Contact
Organization: MFLP
Contact
Person: Suzy Aguilera
Website:
https://blueskyscrubs.com/
Email:
info@blueskyscrubs.com
Contact Number: 18883025837
Country:United States
The post Blue Sky Scrubs Celebrates World Environment Day with Commitment to Sustainability and Innovation appeared first on
Brand News 24.
It is provided by a third-party content
provider. Brand News 24 makes no
warranties or representations in connection with it.
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
GroundingTime Debuts Eco-Friendly Bamboo Grounding Sheet to Redefine Rest
CozyBliss Introduces 2025 COOLI PRO Cooling Comforter Featuring Sorona Technology
Blue Sky Scrubs Celebrates World Environment Day with Commitment to Sustainability and Innovation
Bay Smokes Maintains Quality Amid Legislative Changes in the Hemp Industry
Benzinga Money Article Discusses How to Become Part of the 12% of Retirees Who Have Achieved the Recommended $550,000 Minimum Retirement Savings Threshold
Apu Apustaja Conquers New York with Lively Street Ads, Including Times Square Billboard
-
Press Release5 days ago
The Illusion of Change — A Bold Philosophical Reflection by Adrian Gabriel Dumitru Challenges the True Nature of Transformation
-
Press Release1 week ago
Premium Resources Confirms High-Grade Copper-Nickel Zone in Botswana, Begins Resource Expansion.
-
Press Release6 days ago
Hybrid Collapse Releases Captivating New Album “Biopolitics”
-
Press Release5 days ago
Raven Keiara named Los Angeles finalist for 2025 August Wilson New Voices Monologue Competition
-
Press Release5 days ago
Champion Window Tinting Announces Cutting-Edge Solutions for Energy Savings and Privacy Enhancement
-
Press Release4 days ago
Cloom Tech Offers OEM Wire Harness Manufacturing Solutions
-
Press Release1 week ago
Sleep Dentistry Brisbane Introduces Safe Laughing Gas Sedation for Stress-Free Visits
-
Press Release7 days ago
MeFold Introduces Foldable, Sustainable Water Bottles to Support Eco-Friendly Lifestyles and On-the-Go Hydration